177 related articles for article (PubMed ID: 31654795)
1. Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer.
Toliman PJ; Phillips S; de Jong S; O'Neill T; Tan G; Brotherton JML; Saville M; Kaldor JM; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2020 Jun; 26(6):748-752. PubMed ID: 31654795
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
[TBL] [Abstract][Full Text] [Related]
4. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
Liu W; Gong J; Xu H; Zhang D; Xia N; Li H; Song K; Lv T; Chen Y; Diao Y; Jao J; Dai S; Zhao P; Yao Q
Diagn Cytopathol; 2020 Jul; 48(7):635-644. PubMed ID: 32275355
[TBL] [Abstract][Full Text] [Related]
5. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.
Toliman PJ; Kaldor JM; Badman SG; Gabuzzi J; Silim S; Kumbia A; Kombuk B; Kombati Z; Munnull G; Guy R; Vallely LM; Kelly-Hanku A; Wand H; Ryan C; Tan G; Brotherton J; Saville M; Mola GDL; Garland SM; Tabrizi SN; Vallely AJ
Papillomavirus Res; 2018 Dec; 6():70-76. PubMed ID: 30391365
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
7. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
8. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
[TBL] [Abstract][Full Text] [Related]
9. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
[TBL] [Abstract][Full Text] [Related]
10. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
Wentzensen N; Fetterman B; Tokugawa D; Schiffman M; Castle PE; Wood SN; Stiemerling E; Poitras N; Lorey T; Kinney W
Cancer Cytopathol; 2014 Dec; 122(12):914-20. PubMed ID: 25132656
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
Waldstrøm M; Christensen RK; Ørnskov D
Cancer Cytopathol; 2013 Mar; 121(3):136-45. PubMed ID: 22987560
[TBL] [Abstract][Full Text] [Related]
12. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
[TBL] [Abstract][Full Text] [Related]
13. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ
Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358
[TBL] [Abstract][Full Text] [Related]
14. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
[TBL] [Abstract][Full Text] [Related]
15. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
[TBL] [Abstract][Full Text] [Related]
16. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
[TBL] [Abstract][Full Text] [Related]
17. Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.
Uijterwaal MH; Witte BI; Van Kemenade FJ; Rijkaart D; Ridder R; Berkhof J; Balfoort-van der Meij GA; Bleeker MC; Snijders PJ; Meijer CJ
Br J Cancer; 2014 Mar; 110(6):1579-86. PubMed ID: 24518601
[TBL] [Abstract][Full Text] [Related]
18. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
[No Abstract] [Full Text] [Related]
19. The use of p16/Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure.
Packet B; Poppe W; Weynand B; Vanherck M
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():191-196. PubMed ID: 30007246
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
